140 related articles for article (PubMed ID: 8917376)
1. Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro.
Blomgren H; Edler D; Hallström M; Ragnhammar P
Anticancer Res; 1996; 16(5A):2713-7. PubMed ID: 8917376
[TBL] [Abstract][Full Text] [Related]
2. [Cytotoxic effects of the combination of a new nitrosourea, fotemustine, combined with 5-fluorouracil and folinic acid depend on the sequence of their administration].
Fischel JL; Formento P; Berlion M; Berille J; Gioanni J; Bizzari JP; Milano G
Bull Cancer; 1992; 79(1):81-90. PubMed ID: 1520955
[TBL] [Abstract][Full Text] [Related]
3. A study of various strategies to enhance the cytotoxic activity of 5-fluorouracil/leucovorin in human colorectal cancer cell lines.
Scheithauer W; Temsch EM
Anticancer Res; 1989; 9(6):1793-8. PubMed ID: 2627128
[TBL] [Abstract][Full Text] [Related]
4. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
Moran RG; Scanlon KL
Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of 5-fluorouracil cytotoxicity by folinic acid in different cell-lines of human renal cell carcinoma.
Breul J; Tief G; Hartung R
Eur J Med Res; 1996 Apr; 1(7):339-42. PubMed ID: 9364036
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study of biochemical modulation of 5-fluorouracil with l-leucovorin against human esophageal cancer].
Terashima M; Ikeda K; Kawamura H; Maesawa C; Takiyama I; Yoshinari H; Koeda K; Sato N; Ishida K; Saito K
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1999-2004. PubMed ID: 1417007
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer.
Voboril R; Hochwald SN; Li J; Brank A; Weberova J; Wessels F; Moldawer LL; Camp ER; MacKay SL
J Surg Res; 2004 Aug; 120(2):178-88. PubMed ID: 15234211
[TBL] [Abstract][Full Text] [Related]
8. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.
Thirion P; Michiels S; Pignon JP; Buyse M; Braud AC; Carlson RW; O'Connell M; Sargent P; Piedbois P;
J Clin Oncol; 2004 Sep; 22(18):3766-75. PubMed ID: 15365073
[TBL] [Abstract][Full Text] [Related]
9. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
10. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
Keyomarsi K; Moran RG
Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
[TBL] [Abstract][Full Text] [Related]
12. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T
Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811
[TBL] [Abstract][Full Text] [Related]
13. Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data.
Fischel JL; Etienne MC; Formento P; Milano G
Clin Cancer Res; 1998 Oct; 4(10):2529-35. PubMed ID: 9796987
[TBL] [Abstract][Full Text] [Related]
14. Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells.
Aquino A; Prete SP; Greiner JW; Giuliani A; Graziani G; Turriziani M; De Filippi R; Masci G; Bonmassar E; De Vecchis L
Clin Cancer Res; 1998 Oct; 4(10):2473-81. PubMed ID: 9796980
[TBL] [Abstract][Full Text] [Related]
15. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
16. Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate.
Locke JM; Stutchbury TK; Vine KL; Gamble AB; Clingan PR; Bremner JB; Ranson M
Anticancer Drugs; 2009 Oct; 20(9):822-31. PubMed ID: 19606016
[TBL] [Abstract][Full Text] [Related]
17. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
Tsai CM; Hsiao SH; Frey CM; Chang KT; Perng RP; Gazdar AF; Kramer BS
Cancer Res; 1993 Mar; 53(5):1079-84. PubMed ID: 8382553
[TBL] [Abstract][Full Text] [Related]
18. Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.
Fischel JL; Etienne MC; Spector T; Formento P; Renée N; Milano G
Clin Cancer Res; 1995 Sep; 1(9):991-6. PubMed ID: 9816071
[TBL] [Abstract][Full Text] [Related]
19. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil.
Calviello G; Di Nicuolo F; Serini S; Piccioni E; Boninsegna A; Maggiano N; Ranelletti FO; Palozza P
Cancer Chemother Pharmacol; 2005 Jan; 55(1):12-20. PubMed ID: 15365767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
